Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion type Assertion NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_head.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion description "[Further work is needed to identify optimal platforms for CAR-based adoptive immunotherapy for leukemia, to establish guidelines for managing toxicity, and to determine whether the remissions induced by this approach can be rendered durable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_provenance.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion evidence source_evidence_literature NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_provenance.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion SIO_000772 24319203 NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_provenance.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion wasDerivedFrom befree-2016 NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_provenance.
- NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_assertion wasGeneratedBy ECO_0000203 NP1135056.RAvcSq9wI72cfe2EiCMn26Vyy3pB2isGALPlRkuhEIzUc130_provenance.